Exploring the Therapeutic Effects of Creatine Supplementation for Long COVID-19
ConditionLong COVID Fatigue
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity of Calgary
About this trial
Individuals living with Long COVID often experiencing a degree of undue fatigue after physical or cognitive exertion secondary to the condition, timed post-exertional malaise 9PEM). This trial aims to explore the efficacy of creatine monohydrate in managing PEM
Eligibility criteria
Qualifiers
Experiencing symptoms at least 3 months after a COVID-19 diagnosis confirmed by positive polymerase chain reaction (PCR) test
Experiencing post-exertional malaise, as per the DePaul Symptom Questionnaire
Disqualifiers
Allergy or intolerance to creatine monohydrate or maltodextrin
Supplemented with creatine in the past eight weeks
orthopaedic injury or condition that would prevent exercise testing
change in medication related to Long COVID symptom management in the past month.
Trial design
Treatments tested in this trial
- Creatine monohydrate
Treatment groups
24 Participants
are divided into 2 treatment groupsLocations
This trial has no locations
Sponsors and collaborators
University of Calgary
Lead sponsor
Source ClinicalTrials.gov